Skip to content Skip to sidebar Skip to footer

Tag: Troyen A. Brennan MD MPH

Amgen’s Repatha will be added as the only PCSK9 inhibitor on the CVS/caremark commercial formularies

Repatha™ will be the only PCSK9-inhibitor on the CVS/caremark commercial formularies Provides members with access to high quality drug and helps clients better manage their specialty pharmacy spend WOONSOCKET, RI, 2015-11-24 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today that Repatha™ (evolocumab) from Amgen Inc. will be added as the only PCSK9 inhibitor on…

Read more

CVS Health launches new pharmacy service for patients with multiple medications, ScriptSync™

WOONSOCKET, R.I., 2015-8-12— /EPR Retail News/ — CVS Health (NYSE: CVS) today announced the launch of ScriptSync™, a new pharmacy service that enables patients with multiple medications to pick up their eligible maintenance prescriptions in a monthly CVS/pharmacy visit. In addition, patients or caregivers can manage their ScriptSync prescriptions 24/7 using innovative online support tools. By…

Read more

EPR Retail News